[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

2019 Hemophilia A Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hemophilia A Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hemophilia A. It presents in-depth analysis of Hemophilia A clinical trials across markets and companies ...

April 2019 223 pages

2019 Hemophilia B Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hemophilia B Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hemophilia B. It presents in-depth analysis of Hemophilia B clinical trials across markets and companies ...

April 2019 103 pages

2019 Hemorrhagic Fever Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hemorrhagic Fever Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hemorrhagic Fever. It presents in-depth analysis of Hemorrhagic Fever clinical trials across markets and companies ...

April 2019 217 pages

2019 Hemorrhagic Shock Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hemorrhagic Shock Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hemorrhagic Shock. It presents in-depth analysis of Hemorrhagic Shock clinical trials across markets and companies ...

April 2019 55 pages

2019 Hemorrhoids Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hemorrhoids Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hemorrhoids. It presents in-depth analysis of Hemorrhoids clinical trials across markets and companies ...

April 2019 65 pages

2019 Hemostasis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hemostasis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hemostasis. It presents in-depth analysis of Hemostasis clinical trials across markets and companies ...

April 2019 124 pages

2019 Hepatic Encephalopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatic Encephalopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatic Encephalopathy. It presents in-depth analysis of Hepatic Encephalopathy clinical trials across markets and companies ...

April 2019 96 pages

2019 Hepatic Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatic Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatic Injury. It presents in-depth analysis of Hepatic Injury clinical trials across markets and companies ...

April 2019 97 pages

2019 Hepatic Veno Occlusive Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Hepatic Veno Occlusive Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatic Veno Occlusive Disease. It presents in-depth analysis of Hepatic Veno Occlusive Disease clinical trials ...

April 2019 39 pages

2019 Hepatitis A Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatitis A Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatitis A. It presents in-depth analysis of Hepatitis A clinical trials across markets and companies ...

April 2019 132 pages

2019 Hepatitis D Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatitis D Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatitis D. It presents in-depth analysis of Hepatitis D clinical trials across markets and companies ...

April 2019 80 pages

2019 Hepatitis E Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatitis E Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatitis E. It presents in-depth analysis of Hepatitis E clinical trials across markets and companies ...

April 2019 76 pages

2019 Hepatobiliary Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatobiliary Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatobiliary Disease. It presents in-depth analysis of Hepatobiliary Disease clinical trials across markets and companies ...

April 2019 40 pages

2019 Hepatorenal Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hepatorenal Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hepatorenal Syndrome. It presents in-depth analysis of Hepatorenal Syndrome clinical trials across markets and companies ...

April 2019 54 pages

2019 Hereditary Angioedema (HAE) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hereditary Angioedema (HAE) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hereditary Angioedema (HAE). It presents in-depth analysis of Hereditary Angioedema (HAE) clinical trials ...

April 2019 83 pages

2019 Hernia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hernia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hernia. It presents in-depth analysis of Hernia clinical trials across markets and companies ...

April 2019 249 pages

2019 Herpes Labialis (Oral Herpes) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Herpes Labialis (Oral Herpes) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Herpes Labialis (Oral Herpes). It presents in-depth analysis of Herpes Labialis (Oral Herpes) clinical trials ...

April 2019 56 pages

2019 Herpes Zoster (Shingles) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Herpes Zoster (Shingles) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Herpes Zoster (Shingles). It presents in-depth analysis of Herpes Zoster (Shingles) clinical trials ...

April 2019 175 pages

2019 Heterozygous familial hypercholesterolemia (heFH) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Heterozygous familial hypercholesterolemia (heFH) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Heterozygous familial hypercholesterolemia (heFH). It presents in-depth analysis of Heterozygous familial hypercholesterolemia (heFH) clinical trials ...

April 2019 66 pages

2019 Hidradenitis Suppurativa Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hidradenitis Suppurativa Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hidradenitis Suppurativa. It presents in-depth analysis of Hidradenitis Suppurativa clinical trials across markets and companies ...

April 2019 71 pages

2019 High Grade Glioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 High Grade Glioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for High Grade Glioma. It presents in-depth analysis of High Grade Glioma clinical trials ...

April 2019 337 pages

2019 Hirsutism Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hirsutism Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hirsutism. It presents in-depth analysis of Hirsutism clinical trials across markets and companies ...

April 2019 45 pages

2019 Histoplasmosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Histoplasmosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Histoplasmosis. It presents in-depth analysis of Histoplasmosis clinical trials across markets and companies ...

April 2019 39 pages

2019 HIV-Associated Lipodystrophy Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 HIV-Associated Lipodystrophy Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for HIV-Associated Lipodystrophy Syndrome. It presents in-depth analysis of HIV-Associated Lipodystrophy Syndrome clinical trials ...

April 2019 38 pages

2019 Homozygous Familial Hypercholesterolemia (HoFH) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Homozygous Familial Hypercholesterolemia (HoFH) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Homozygous Familial Hypercholesterolemia (HoFH). It presents in-depth analysis of Homozygous Familial Hypercholesterolemia (HoFH) clinical trials ...

April 2019 60 pages

2019 Hookworm Infections (Ancylostomiasis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hookworm Infections (Ancylostomiasis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hookworm Infections (Ancylostomiasis). It presents in-depth analysis of Hookworm Infections (Ancylostomiasis) clinical trials ...

April 2019 51 pages

2019 Hormonal Contraception Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hormonal Contraception Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hormonal Contraception. It presents in-depth analysis of Hormonal Contraception clinical trials across markets and companies ...

April 2019 62 pages

2019 Hormone Deficiency Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hormone Deficiency Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hormone Deficiency Disorders. It presents in-depth analysis of Hormone Deficiency Disorders clinical trials ...

April 2019 134 pages

2019 Hormone Refractory Breast Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Hormone Refractory Breast Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hormone Refractory Breast Cancer. It presents in-depth analysis of Hormone Refractory Breast Cancer clinical trials ...

April 2019 44 pages

2019 Hormone Sensitive Breast Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Hormone Sensitive Breast Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hormone Sensitive Breast Cancer. It presents in-depth analysis of Hormone Sensitive Breast Cancer clinical trials ...

April 2019 46 pages

2019 Hormone-Sensitive Prostate Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hormone-Sensitive Prostate Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hormone-Sensitive Prostate Cancer. It presents in-depth analysis of Hormone-Sensitive Prostate Cancer clinical trials ...

April 2019 71 pages

2019 Hospital Acquired Pneumonia (HAP) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Hospital Acquired Pneumonia (HAP) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hospital Acquired Pneumonia (HAP). It presents in-depth analysis of Hospital Acquired Pneumonia (HAP) clinical trials ...

April 2019 268 pages

2019 Hot Flashes Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hot Flashes Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hot Flashes. It presents in-depth analysis of Hot Flashes clinical trials across markets and companies ...

April 2019 117 pages

2019 House Dust Mite Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 House Dust Mite Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for House Dust Mite Allergy. It presents in-depth analysis of House Dust Mite Allergy clinical trials ...

April 2019 142 pages

2019 Human Papillomavirus (HPV) Associated Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Human Papillomavirus (HPV) Associated Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Human Papillomavirus (HPV) Associated Cancer. It presents in-depth analysis of Human Papillomavirus (HPV) Associated Cancer ...

April 2019 149 pages

2019 Human Papillomavirus Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Human Papillomavirus Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Human Papillomavirus Infections. It presents in-depth analysis of Human Papillomavirus Infections clinical trials ...

April 2019 213 pages

2019 Huntington Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Huntington Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Huntington Disease. It presents in-depth analysis of Huntington Disease clinical trials across markets and companies ...

April 2019 100 pages

2019 Hyper Pigmentation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyper Pigmentation Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyper Pigmentation. It presents in-depth analysis of Hyper Pigmentation clinical trials across markets and companies ...

April 2019 96 pages

2019 Hyperalgesia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperalgesia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperalgesia. It presents in-depth analysis of Hyperalgesia clinical trials across markets and companies ...

April 2019 135 pages

2019 Hyperammonemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperammonemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperammonemia. It presents in-depth analysis of Hyperammonemia clinical trials across markets and companies ...

April 2019 42 pages

2019 Hyperandrogenism Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperandrogenism Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperandrogenism. It presents in-depth analysis of Hyperandrogenism clinical trials across markets and companies ...

April 2019 71 pages

2019 Hyperbilirubinemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperbilirubinemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperbilirubinemia. It presents in-depth analysis of Hyperbilirubinemia clinical trials across markets and companies ...

April 2019 78 pages

2019 Hypercalcemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hypercalcemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hypercalcemia. It presents in-depth analysis of Hypercalcemia clinical trials across markets and companies ...

April 2019 60 pages

2019 Hyperemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperemia. It presents in-depth analysis of Hyperemia clinical trials across markets and companies ...

April 2019 55 pages

2019 Hypereosinophilic Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hypereosinophilic Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hypereosinophilic Syndrome. It presents in-depth analysis of Hypereosinophilic Syndrome clinical trials across markets and companies ...

April 2019 75 pages

2019 Hyperglycemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperglycemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperglycemia. It presents in-depth analysis of Hyperglycemia clinical trials across markets and companies ...

April 2019 421 pages

2019 Hyperinsulinemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperinsulinemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperinsulinemia. It presents in-depth analysis of Hyperinsulinemia clinical trials across markets and companies ...

April 2019 98 pages

2019 Hyperkalemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperkalemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperkalemia. It presents in-depth analysis of Hyperkalemia clinical trials across markets and companies ...

April 2019 71 pages

2019 Hyperparathyroidism Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperparathyroidism Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperparathyroidism. It presents in-depth analysis of Hyperparathyroidism clinical trials across markets and companies ...

April 2019 182 pages

2019 Hyperphenylalaninemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Hyperphenylalaninemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperphenylalaninemia. It presents in-depth analysis of Hyperphenylalaninemia clinical trials across markets and companies ...

April 2019 210 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers